LACTYFERRIN™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Patients With COVID-19

NCT05783180 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor decided not to move forward with the trial

Conditions

COVID-19

Interventions

DRUG: Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™
DRUG: Placebo

Sponsor

Jose David Suarez, MD

Collaborators

[object Object]
[object Object]
[object Object]